- 全部删除
- 您的购物车当前为空
GLP-1(7-36), amide acetate(胰高血糖素样肽-1(7-36)酰胺醋酸盐)是GLP-1的衍生物。GLP-1(7-36), amide能够激活GLP-1受体,具有促进胰岛素分泌和抑制胰高血糖素分泌的作用,具有治疗2型糖尿病和肥胖的潜力。
GLP-1(7-36), amide acetate(胰高血糖素样肽-1(7-36)酰胺醋酸盐)是GLP-1的衍生物。GLP-1(7-36), amide能够激活GLP-1受体,具有促进胰岛素分泌和抑制胰高血糖素分泌的作用,具有治疗2型糖尿病和肥胖的潜力。
规格 | 价格 | 库存 | 数量 |
---|---|---|---|
500 μg | ¥ 993 | In stock | |
1 mg | ¥ 1,650 | In stock | |
5 mg | ¥ 4,970 | In stock | |
10 mg | ¥ 6,880 | In stock | |
25 mg | ¥ 9,870 | In stock | |
50 mg | ¥ 13,700 | In stock | |
100 mg | ¥ 18,500 | In stock |
GLP-1(7-36), amide acetate 相关产品
产品描述 | GLP-1(7-36), amide acetate is a derivative of GLP-1 peptide (glucagon-like peptide-1).GLP-1(7-36), amide is able to activate the GLP-1 receptor, which has the ability to promote insulin secretion and inhibit glucagon secretion, with the potential to treat type 2 diabetes mellitus and obesity. |
体外活性 | Cells treated with phorbol 12-myristate 13-acetate for 2 h has significantly higher active GLP-1(7-36) concentrations in the media compares to the control. The glucose treatment also increases active GLP-1 secretion from cells in dose-dependent manner. Palmitic, oleic, linoleic or linolenic acid dose-dependently stimulated active GLP-1 secretion from cells. Active GLP-1 secretion is significantly greater with unsaturated fatty acids such as oleic, linoleic and linolenic acids than with palmitic acid. The treatment of NCI-H716 cells with CPE dose-dependently increases active GLP-1 concentrations in the media. A 37% increase is observed in active GLP-1 secretion from these cells at a concentration of 0.1 % CPE[1]. |
体内活性 | 葡萄糖的胃部给药增加了门静脉中的活性 GLP-1(7-36), amide acetate水平 10 分钟后血液,随后活性 GLP-1 水平显着降低 30 分钟 。胃部给药 10 分钟后,TO 活性 GLP-1 水平也增加,随后降至 60 分钟时的基础水平。[1] |
别名 | 胰高血糖素样肽-1(7-36)酰胺醋酸盐, Human GLP-1 (7-36), amide acetate, Glucagon-like peptide-1 (GLP-1)(7-36), amide acetate |
分子量 | 3357.68 |
分子式 | C151H230N40O47 |
CAS No. | 1119517-19-9 |
Smiles | C(C)(O)=O.C([C@@H](C(N[C@H](C(N[C@H](C(N[C@H](C(NCC(N[C@@H](CCCNC(=N)N)C(N)=O)=O)=O)CCCCN)=O)[C@@H](C)C)=O)CC(C)C)=O)NC([C@@H](NC([C@@H](NC([C@H](CC1=CC=CC=C1)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC(CNC([C@@H](NC([C@@H](NC([C@H](CC2=CC=C(O)C=C2)NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@@H](NC([C@H](CC3=CC=CC=C3)NC([C@@H](NC(CNC([C@@H](NC([C@@H](NC([C@H](CC4=CN=CN4)N)=O)C)=O)CCC(O)=O)=O)=O)[C@@H](C)O)=O)=O)[C@@H](C)O)=O)CO)=O)CC(O)=O)=O)C(C)C)=O)CO)=O)CO)=O)=O)CC(C)C)=O)CCC(O)=O)=O)=O)CCC(N)=O)=O)C)=O)C)=O)CCCCN)=O)CCC(O)=O)=O)=O)[C@H](CC)C)=O)C)=O)C=5C=6C(NC5)=CC=CC6 |
密度 | no data available |
Sequence | His-Ala-Glu-Gly-Thr-Phe-Thr-Ser-Asp-Val-Ser-Ser-Tyr-Leu-Glu-Gly-Gln-Ala-Ala-Lys-Glu-Phe-Ile-Ala-Trp-Leu-Val-Lys-Gly-Arg-NH2 |
Sequence Short | HAEGTFTSDVSSYLEGQAAKEFIAWLVKGRNH2 |
存储 | keep away from moisture | Powder: -20°C for 3 years | In solvent: -80°C for 1 year | Shipping with blue ice/Shipping at ambient temperature. | |||||||||||||||||||||||||
溶解度信息 | H2O: 80.00 mg/mL (23.83 mM), Sonication is recommended. | |||||||||||||||||||||||||
溶液配制表 | ||||||||||||||||||||||||||
H2O
|
以上为“体内实验配液计算器”的使用方法举例,并不是具体某个化合物的推荐配制方式,请根据您的实验动物和给药方式选择适当的溶解方案。
评论内容